Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 60 of 2541 for:    "Plasma Cell Neoplasm"

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03689595
Recruitment Status : Recruiting
First Posted : September 28, 2018
Last Update Posted : August 2, 2019
Sponsor:
Collaborator:
Stand Up To Cancer
Information provided by (Responsible Party):
Irene Ghobrial, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 31, 2033
  Estimated Study Completion Date : October 31, 2033